Share
3,600 Posts.
lightbulb Created with Sketch. 174
clock Created with Sketch. 11/02/20
02:25
Share
Originally posted by siciliavin
↑
Certainly a strong possibility .......... Biotron has several early stage programs designing drugs that target a class of virus protein known as viroporins. Viroporins play a key role in the virus life cycle of a very broad range of viruses, many of which have caused worldwide health issues. These include the likes of Dengue, Ebola, Middle East Respiratory virus, Influenza, Zika, and Coronavirus. On Thursday Biotron announced that it is in the process of evaluating several promising compounds including Within its proprietary small molecule compound library, the company has over 30 compounds which have good activity against a range of other coronaviruses. These includes human coronaviruses that cause mild, cold-like symptoms, as well as the SARS coronavirus that was responsible for the outbreak of that virus in 2003. These compounds have previously been able to reduce the levels of coronavirus by 90% to 100% in infected cell cultures. With some even having broad-spectrum activity against multiple strains of coronaviruses. This has sparked hopes that Biotron may have a compound that is effective against the 2019-nCoV strain. What now? Biotron is focusing its efforts on testing a select set of its compounds against the new 2019-nCoV strain. This work is being conducted under contract i n specialist laboratories that have gained access to the new virus in recent days.
Expand
Been doing some early morning digging.. more and more I search more and more I think it’s BIT.. https://www.health.nsw.gov.au/news/Pages/20200210_01.aspx
